CoChat

Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus

Open access
Levendosky, Keith, Mizenina, Olga, Martinelli, Elena, Jean-Pierre, Ninochka, Kizima, Larisa, Rodriguez, Aixa, Kleinbeck, Kyle, Bonnaire, Thierry, Robbiani, Melissa, Zydowsky, Thomas M., O'Keefe, Barry R., Fernández-Romero, José A. · 2015 · Antimicrobial Agents and Chemotherapy
Cited by 99

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Extensive preclinical evaluation of griffithsin (GRFT) has identified this lectin to be a promising broad-spectrum microbicide. We set out to explore the antiviral properties of a GRFT and carrageenan (CG) combination product against herpes simplex virus 2 (HSV-2) and human papillomavirus (HPV) as well as determine the mechanism of action (MOA) of GRFT against both viruses. We performed the experiments in different cell lines, using time-of-addition and temperature dependence experiments to differentiate inhibition of viral attachment from entry and viral receptor internalization. Surface plasmon resonance (SPR) was used to assess GRFT binding to viral glycoproteins, and immunoprecipitation and immunohistochemistry were used to identify the specific glycoprotein involved. We determined the antiviral activity of GRFT against HSV-2 to be a 50% effective concentration (EC 50 ) of 230 nM and provide the first evidence that GRFT has moderate anti-HPV activity (EC 50 = 0.429 to 1.39 μM). GRFT blocks the entry of HSV-2 and HPV into target cells but not the adsorption of HSV-2 and HPV onto target cells. The results of the SPR, immunoprecipitation, and immunohistochemistry analyses of HSV-2 combined suggest that GRFT may block viral entry by binding to HSV-2 glycoprotein D. Cell-based assays suggest anti-HPV activity through α 6 integrin internalization. The GRFT-CG combination product but not GRFT or CG alone reduced HSV-2 vaginal infection in mice when given an hour before challenge ( P = 0.0352). While GRFT significantly protected mice against vaginal HPV infection when dosed during and after HPV16 pseudovirus challenge ( P < 0.026), greater CG-mediated protection was afforded by the GRFT-CG combination for up to 8 h ( P < 0.0022). These findings support the development of the GRFT-CG combination as a broad-spectrum microbicide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.01816-15

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 99

Metadata

Authors
Levendosky, K., Mizenina, O., Martinelli, E., Jean-Pierre, N., Kizima, L., Rodriguez, A., Kleinbeck, K., Bonnaire, T., Robbiani, M., Zydowsky, T. M., O'Keefe, B. R., & Fernández-Romero, J. A.
Venue
Antimicrobial Agents and Chemotherapy
Published
2015-12
Volume
59
Issue
12
Pages
7290-7298
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2238130276
Cited by
99
References
2
FWCI
4.82
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus. https://app.cochat.ai/papers/10.1128/aac.01816-15
The paper
Levendosky, K., Mizenina, O., Martinelli, E., Jean-Pierre, N., Kizima, L., Rodriguez, A., Kleinbeck, K., Bonnaire, T., Robbiani, M., Zydowsky, T. M., O'Keefe, B. R., & Fernández-Romero, J. A. (2015). Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01816-15

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.